U.S. Healthcare Services Stock News

In recent months, Driehaus Capital Management and Deerfield Management Company have sharply increased their holdings in Praxis Precision Medicines, adding hundreds of thousands of shares and committing a combined investment of more than US$346.79 million as the company filed two FDA new drug applications for ulixacaltamide and relutrigine. This combination of larger institutional ownership, advancing late‑stage neuroscience candidates and a cash position supported by roughly US$1.55 billion...

Earlier in March, Federated Hermes announced that four of its investment strategies received LSEG Lipper Fund Awards 2026 US for consistently strong risk‑adjusted performance, while CEO J. Christopher Donahue is scheduled to present at the RBC Capital Markets Global Financial Institutions Conference 2026 in New York on March 11. This combination of third‑party recognition and high recent earnings growth and return on equity is sharpening attention on how effectively Federated Hermes converts...

In early March 2026, Clarivate Plc announced it had integrated its Cortellis Regulatory Intelligence data with Anthropic’s Claude via the open Model Context Protocol, giving biopharma, biotech, medtech and clinical research organizations context-aware access to authoritative regulatory data directly within their existing AI workflows. This move highlights how Clarivate is aiming to embed its validated regulatory content deeper into customers’ day-to-day decision processes, potentially...

In March 2026, Silvaco Group, Inc. completed a follow-on at-the-market US$15 million common stock offering and reported full-year 2025 revenue of US$63.06 million with a net loss of US$41.21 million, alongside guidance for first-quarter 2026 revenue of US$15 million to US$19 million. A few days earlier, the company also announced the immediate availability of Mixel MIPI Production Ready Offerings, broadening its silicon-proven mixed-signal interface IP portfolio across advanced process nodes...

EHang Holdings Limited reported its fourth-quarter 2025 results on March 12, 2026, with sales rising to CNY 243.78 million and quarterly net income reaching CNY 10.49 million, while full-year 2025 revenue increased to CNY 509.50 million alongside a full-year net loss of CNY 230.54 million. The shift from a quarterly net loss in the prior year to profitability in Q4 2025, even as the full year remained loss-making, highlights a meaningful improvement in operating performance and cost...

Why Evercore (EVR) is on investors’ radar today Evercore (EVR) has drawn fresh attention after a period of mixed share performance, with a recent 0.4% daily gain that contrasts with weaker moves over the past week, month, and past 3 months. See our latest analysis for Evercore. That 0.4% 1 day share price gain comes after a tougher spell, with a 7.2% 7 day share price decline and a 23.6% year to date share price decline, even though the 1 year total shareholder return is 35.1% and the 3 year...

Wynn Resorts has resumed construction on its US$5.10 billion Wynn Al Marjan Island integrated resort in Ras Al Khaimah, UAE, after a brief security-related pause, while maintaining close coordination with US and UAE authorities to safeguard employees and operations. This restart reinforces Wynn’s push into the Middle East through a 40% stake in the project, marking the region’s first large-scale casino resort and expanding its luxury hospitality footprint beyond existing US and Asia...

If you are wondering whether Enova International at around US$134.11 is still offering value or already pricing in a lot of optimism, you are asking the right question for this stock. The share price has seen a 2.5% decline over the last 7 days and a 10.1% decline over the last 30 days, although the 1 year return sits at 44.8% and the 3 year return is 220.5%, with 5 year returns at 266.4%. Recent coverage of Enova International has focused on its position within the diversified financials...

On Holding (NYSE:ONON) is back in focus after releasing its 2025 results and outlining 2026 guidance, with management expecting at least 23% constant currency net sales growth to a minimum CHF 3.44b. See our latest analysis for On Holding. The latest guidance and 2025 numbers arrive after a softer patch for the shares. The 30 day share price return is 16.12%, and the year to date share price return is a 19.08% decline. However, the 3 year total shareholder return of 75.80% shows that longer...

Earlier this month, Surgery Partners, Inc. reported 2025 results showing higher sales of US$885.0 million for the fourth quarter and US$3.31 billion for the year but continuing net losses, issued softer 2026 revenue guidance of US$3.35 billion to US$3.45 billion, launched a new US$200.0 million share repurchase program, and appointed veteran health system executive Lloyd Dean as an independent director. These developments, alongside pressure from activist investor Ortelius Advisors pushing...

Why Autodesk (ADSK) Is Back in Focus Autodesk (ADSK) is back on investors’ radar after management reported better than expected quarterly results, announced a 7% workforce reduction, and signaled higher investment in AI, cloud, and construction platforms. See our latest analysis for Autodesk. Autodesk’s US$251.17 share price reflects a mixed year, with a 30 day share price return of 8.63%, a 90 day share price return of 14.66%, and a year to date share price return of 12.40%. The 3 year total...

Corvus Pharmaceuticals stock moves after recent performance swings Corvus Pharmaceuticals (CRVS) has been drawing fresh attention as its share price reflected sharp recent moves, including a 4.3% decline over the past day and a month return that is roughly 17.9% lower. See our latest analysis for Corvus Pharmaceuticals. Even with the latest 4.3% one day share price decline and a softer 30 day share price return of 17.9%, Corvus Pharmaceuticals still shows strong upward momentum, with a 90 day...

If you are wondering whether Coherent is still fairly priced after its run, you are not alone. Many investors are now asking what the current share price actually reflects. The stock most recently closed at US$242.76, with reported returns of 3.0% over 7 days, 11.8% over 30 days, 24.9% year to date, a very large 1 year return, and a multi-year return above 7x over 3 years and 251.5% over 5 years. Recent news coverage has focused on Coherent's position in photonics and laser technologies,...

Emerson Electric (EMR) has drawn fresh attention after reporting quarterly earnings that exceeded analyst expectations, raising full year earnings guidance and outlining plans for a US$250 million buyback and US$10 billion in shareholder returns by 2028. See our latest analysis for Emerson Electric. Despite the earnings beat and higher guidance, recent share price returns have been soft, with a 30 day share price return of 10.73% and a year to date share price return of 2.64%. In contrast,...

Recent analyst commentary on New Oriental Education & Technology Group (EDU) has focused on its valuation and cash flow metrics. It has highlighted how these measures compare with sector averages and has tied that information to a constructive earnings outlook. See our latest analysis for New Oriental Education & Technology Group. The recent 1-day share price return of 0.73% and 7-day share price return of 2.28% sit against a 30-day share price decline of 8.23% and year to date share price...

Winmark Corp recently passed the Caviar Cruise quality investing screen, which highlights companies with durable competitive strengths, high profitability, and solid financial health. This recognition emphasizes Winmark’s franchise-based model, where high returns on invested capital and strong cash flow conversion underpin its operational quality. We’ll now examine how Winmark’s very high return on invested capital shapes the company’s investment narrative following these quality-focused...

Why Verisk’s new buyback is drawing fresh attention Verisk Analytics (VRSK) has come back into focus after launching a $1.5b accelerated share repurchase program and stepping up investor outreach through an Analyst and Investor Day plus back to back conference appearances. See our latest analysis for Verisk Analytics. The 1 month share price return of 11.04% and 1 day move of 1.61% to US$201.22 sit against a 1 year total shareholder return of 29.73% decline. The recent buyback announcement...

If you are wondering whether Firefly Aerospace's current share price lines up with its underlying worth, this article will walk through what the available data can and cannot tell you about value. Over the last week the stock recorded a 19% return and a 21.6% return over the last month. The year to date return sits at a 1.2% decline. Taken together, these figures suggest the market has recently been reassessing the share price. Recent news coverage has focused on Firefly Aerospace's position...

Amalgamated Financial (AMAL) is back in focus after reporting fourth quarter 2025 earnings, with revenue of $87.91 million that topped forecasts, alongside continued insider share sales by a senior executive. See our latest analysis for Amalgamated Financial. The latest quarterly update and ongoing insider selling come against a mixed price backdrop, with a 1 day share price return of 0.37% and a 30 day share price decline of 7.95%, while the 90 day share price return of 18.10% and 1 year...

Pinnacle West Capital (PNW) is back on investors’ radar after fourth quarter earnings per share came in ahead of expectations, even as revenue missed forecasts. This comes alongside fresh guidance and rising institutional ownership. See our latest analysis for Pinnacle West Capital. The recent earnings beat, fresh EPS guidance and mixed institutional moves have come alongside a 90 day share price return of 16.45% and a 1 year total shareholder return of 14.25%. The 3 year total shareholder...

Turning Point Brands recently reported fourth-quarter 2025 sales of US$121.01 million and full-year sales of US$463.06 million, alongside 2026 Modern Oral gross revenue guidance of US$220 million to US$240 million and net revenue guidance of US$180 million to US$190 million. At the same time, FRE® Nicotine Pouches’ new NASCAR Cup Series partnership with 23XI Racing and driver Riley Herbst signals a push to broaden brand reach and retail penetration, particularly in the Las Vegas...

Earlier this week, Madison Square Garden Sports Corp. and Blueair announced a partnership making Blueair the Official Air Care Partner of the New York Knicks, integrating its air wellness technology into the Knicks’ training center and prominent digital and in-arena platforms. Beyond branding, the collaboration underscores how MSG Sports continues to monetize the Knicks’ profile through specialized sponsorships that link performance, health, and fan engagement across multiple channels. Next,...

Earlier this month, Silicon Motion Technology Corporation launched the SM8008, a PCIe Gen5 x4 NVMe enterprise SSD controller built on TSMC 6nm, targeting power-efficient data center boot drives with up to 14GB/s throughput, over 2.3 million 4K random IOPS, and extensive enterprise-grade security features across multiple server form factors. This move highlights Silicon Motion’s push to carve out dedicated boot storage as a distinct enterprise segment, aligning its controller roadmap with...

In early March 2026, YETI Holdings participated in back-to-back consumer and retail conferences hosted by Citi and Bank of America in the Miami area, outlining its outlook to institutional investors. Soon after these appearances, Morgan Stanley raised fresh concerns about YETI’s weaker 2026 guidance and earnings trajectory, sharpening investor focus on the company’s medium-term performance risks. With Morgan Stanley’s cautious commentary on YETI’s 2026 outlook now on the table, we’ll...